en · de · es · pt
methods-notes.peptides6908.com › Wiki › Melanotan-2 Identity And Regulatory Status — Reference Sheet

Melanotan-2 Identity And Regulatory Status — Reference Sheet

By Editorial Desk · published 2026-05-03 · last reviewed 2026-06-05 · Wiki

The short version of Melanotan II fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2026-06-05. Anything still debated is marked as such rather than presented as settled.

Melanotan-2 Identity And Regulatory Status

Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.

Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.

Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.

Quality Control and Analytical Practice

Identity testing for a synthetic peptide relies on several complementary methods. Reversed-phase high-performance liquid chromatography separates the target from related impurities and reports purity as a percentage of total peak area. Mass spectrometry confirms molecular mass and can reveal deletions or truncations. Amino acid analysis and peptide mapping provide sequence-level confirmation, while counter-ion content and residual solvents are measured separately. A purity figure alone does not establish identity, so a complete dataset combines chromatographic and spectrometric evidence.

Lyophilized peptide powder is generally stored frozen, protected from light and moisture. Tryptophan residues are susceptible to oxidation, and the lactam bridge can hydrolyze under strongly acidic or basic conditions. Solutions prepared for laboratory work degrade faster than dry powder, and repeated freeze-thaw cycles accelerate loss. Common practice is to aliquot solutions before freezing and to avoid alkaline buffers. Reported stability windows vary with concentration, buffer, and temperature, so exact shelf lives are method-specific rather than universal.

Regulatory status differs by country, and in many places supplying the compound for human consumption is unlawful. Vendors frequently label material as intended for research use only, a designation that shifts stated purpose but does not create a legal pathway for personal use. Certificates of analysis accompanying such products vary widely in detail and provenance. Third-party testing exists but is voluntary, and results are rarely linked to a specific lot in a publicly verifiable way.

Melanotan-2 at a glance

PropertyValueNotes
Chemical classSynthetic cyclic heptapeptideAnalogue of alpha-melanocyte-stimulating hormone
Common synonymsMT-II; melanotan 2No internationally accepted non-proprietary name
Typical presentationLyophilised powder in a sealed vialOften supplied alongside a separate diluent
Regulatory statusUnapproved therapeutic substanceCustoms seizure reported in several jurisdictions
Reported route in useSubcutaneous injectionSelf-administered outside clinical settings

Origins and Research Status

Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.

The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.

Related pages on this site

Regulatory Status and Analytical Detection

The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.

Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.

Reference notes

==== Albums ==== Opus (Opus album), 1987, by Austrian band Opus Opus (Schiller album), 2013, by German music project Schiller Opus, 2014, by Jane Badler Opus (Eric Prydz album), 2016, by the electronic artist Eric Prydz "Opus" (Eric Prydz song), song from the eponymous album Opus, a 2007 compilation album by Mr. Sam Opus (Marc Anthony album), 2019, by Puerto Rican singer Marc Anthony

Alzheimer's financial burden on society is large, with an estimated global annual cost of US$1 trillion. Alzheimer's and related dementias are ranked as the seventh leading cause of death worldwide. Given the widespread impacts of Alzheimer's disease, both basic-science and health funders in many countries support Alzheimer's research at large scales. For example, the US National Institutes of Health program for Alzheimer's research, the National Plan to Address Alzheimer's Disease, has a budget of US$3.98 billion for fiscal year 2026. In the European Union, the 2020 Horizon Europe research programme awarded over €570 million for dementia-related projects.

In January 2022, the business announced it would acquire Affera, Inc. In March, Medtronic announced a contract with Vizient, a healthcare performance improvement company, to add Medtronic's Touch Surgery Enterprise platform to Vizient's healthcare offerings. Touch Surgery works with laparoscopic and robotic scopes and is an AI-powered video management and analytics platform for the operating room. In May, Medtronic and DaVita Inc. announced plans to form a new, independent kidney care-focused medical device company. Medtronic's Renal Care Solutions business will be part of the new company. In April 2022, the company announced a collaboration with GE Healthcare to support the needs and care demands at Ambulatory Surgery Centers. In July, Medtronic announced a strategic partnership with CathWorks, a coronary artery disease (CAD) technology developer. A separate agreement gave Medtronic the option to acquire CathWorks in the future. In October 2022, the company announced its intention to pursue a separation of the company's combined Patient Monitoring and Respiratory Interventions businesses, which are part of the company's Medical Surgical Portfolio. In February 2024, the company announced that it had reversed its decision to spin off or sell the Patient Monitoring and Respiratory Interventions businesses, and would instead combine them into a new business unit called Acute Care & Monitoring. They also announced that they would discontinue the ventilator product line, citing its unprofitability.

Sources: en.wikipedia.org

Notes from published material

Along their route, they visited cocoa and sugar cane plantations—operations that, much to Humboldt’s dismay, were still worked by enslaved laborers. In these cultivated areas, Humboldt studied water management issues. He observed that deforestation had interrupted the natural water cycle: the loss of forests as reservoirs led to severe soil desiccation under the relentless sun. At Lake Valencia, he recognized that the lake’s water level had once been higher and warned that continued settlement and irrigation would cause further decline—a prediction since borne out, as the lake has lost a third of its volume. He also took a keen interest in the municipal systems of the settlements, criticizing the Spanish colonial policy that stifled local self-government and, in his view, suppressed economic development. Despite these structural problems, the travelers, armed with letters of recommendation, received warm welcomes in each village and town. One of Humboldt’s most memorable encounters in the Aragua valleys was with the remarkable palo de vaca or cow tree (also called “arbol de leche,” the milk tree), a species previously unknown to European science. Although the tree resembled the unremarkable star apple, it possessed an extraordinary quality: when its trunk was cut, it oozed a thick, fragrant, drinkable sap—essentially, plant milk. Humboldt and Bonpland sampled this sap without ill effect and watched as the indigenous people tapped the trees at sunrise, collecting the milk in bowls to drink or carry home.

== History == Macrophages were first discovered late in the 19th century by zoologist Élie Metchnikoff. Metchnikoff revolutionized the branch of macrophages by combining philosophical insights and the evolutionary study of life. Later on, Van Furth during the 1960s proposed the idea that circulating blood monocytes in adults allowed for the origin of all tissue macrophages. In recent years, publishing regarding macrophages has led people to believe that multiple resident tissue macrophages are independent of the blood monocytes as it is formed during the embryonic stage of development. Within the 21st century, all the ideas concerning the origin of macrophages (present in tissues) were compiled together to suggest that physiologically complex organisms, from macrophages independently by mechanisms that don't have to depend on the blood monocytes.

== Culture == Most of the district's news media has been either weekly or monthly publications. The earliest newspaper was the Scarborough News and Advertiser which was published weekly starting in September 1921, which lasted until the 1930s. Other short-lived papers and magazines included The Enterprise (1945–1966), Scarborough Mail (1946–1955) and The News (1952–1996) and 54east magazine (2005–2009). The last remaining English-language local newspaper was the Scarborough Mirror, which started publication in 1962 and was later acquired by the Toronto Star's community news division, Metroland. In 2023, it became an online-only publication as part of Toronto.com. A Scarborough edition of the Toronto-wide photography publication SNAP Scarborough was launched in 2009. Ming Pao Daily News is a Chinese-language newspaper whose headquarters is in the district. They started publication in 1993. In 1961, the CTV Toronto (CFTO) television channel began operating from the 9 Channel Nine Court studios at the intersection of McCowan Road and Highway 401. Today, the studio also is the headquarters of The Sports Network (TSN). Both companies produce programming at the studio. In 1970, Trillium Cable started to provide cable TV service to Scarborough. It was purchased by Shaw Cable in 1995; but later swapped with Rogers Cable in 2001. During the early days of the company, they produced several local shows for their own cable channel. These shows were produced by volunteers and showed a wide variation in quality. These shows were satirized by Mike Myers in his comedy film Wayne's World.

Sources: en.wikipedia.org

Frequently asked questions

Is melanotan II approved for medical use?

No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.

Where did melanotan II originate?

It was developed in the 1980s by researchers investigating analogues of alpha-melanocyte-stimulating hormone for pigmentation and related endpoints. Early work included small human studies during the 1990s. Development did not progress to licensing, and the compound remained a research and grey-market item.

Why is purity a concern for unapproved peptides?

Peptides are prone to truncation, oxidation and aggregation during synthesis and handling. Without independent testing, a buyer cannot confirm the identity or the content of a vial. Analytical surveys of unapproved peptide products have repeatedly found discrepancies between label claims and measured composition.

What conditions keep a lyophilized peptide stable?

Dry powder is usually held frozen, shielded from light, and kept away from moisture. Desiccant packaging limits hydrolysis during storage. Solutions are typically aliquoted and frozen once, because repeated thawing shortens useful life.

Network